Cardiac nuclear medicine in monitoring patients with coronary heart disease

Seminars in Nuclear Medicine

Volumn 31, Issue 3, 2001, Pages 223-237

  Parker, J Anthony ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; HEART DISEASE; HEART MUSCLE PERFUSION; HIGH RISK PATIENT; HUMAN; PATIENT MONITORING; PATIENT SELECTION; PROGNOSIS; REVASCULARIZATION; REVIEW; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0034978797     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/snuc.2001.23529     Document Type: Article

References (192)

1. Present state and future role of gallium-67 scintigraphy in lymphoma
2. Studies on the velocity of blood flow. I. The method utilized
3. Studies on the velocity of blood flow. II. The velocity of blood flow in normal resting individuals, and a critique of the method used
4. Studies on the velocity of blood flow. III. The velocity of blood flow and its relation to other aspects of the circulation in patients with rheumatic and syphilitic heart disease
5. Studies on the velocity of blood flow. IV. The velocity of blood flow and its relation to other aspects of the circulation in patients with arteriosclerosis and in patients with arterial hypertension
6. Studies on the velocity of blood flow. V. The physiological and the pathological significance of the velocity of blood flow
7. Studies on the velocity of blood flow. VI. The method of collecting the active deposit of radium and its preparation for intravenous injection
8. Studies on the velocity of blood flow. VII. The pulmonary circulation time in normal resting individuals
9. Studies on the velocity of blood flow. VIII. The velocity of blood flow and its relation to other aspects of the circulation in patients with pulmonary emphysema
10. Treatment of incapacitated euthyroid cardiac patients with radioactive iodine: Summary of results in treatment of 1070 patients with angina pectoris or congestive failure
11. Quantitative radionuclide angiocardiography: Determination of the Qp:Qs in children
12. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography
13. Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionuclide angiography
14. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography
15. Noninvasive evaluation of regional myocardial perfusion with potassium 43. Technique in patients with exercise-induced transient myocardial ischemia
16. Noninvasive regional myocardial perfusion with radioactive potassium. Study of patients at rest, with exercise and during angina pectoris
17. Myocardial imaging with thallium-201: A multicenter study in patients with angina pectoris or acute myocardial infarction
18. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain
19. Prognostic implications of exercise thallium-201 scintigraphy in patients with suspected or known coronary artery disease
20. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease
21. Exercise thallium-201 scintigraphy in men with nondiagnostic exercise electrocardiograms. Prognostic implications
22. Prediction of death, myocardial infarction, and worsening chest pain using thallium scintigraphy and exercise electrocardiography
23. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease
24. Exercise thallium imaging in patients with diabetes mellitus. Prognostic implications
25. Usefulness of residual ischemic myocardium within prior infarct zone for identifying patients at high risk late after acute myocardial infarction
26. Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary artery disease
27. Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: A comparison with cardiac catheterization
28. Prognostic utility of the exercise thallium-201 test in ambulatory patients with chest pain: Comparison with cardiac catheterization
29. Prognostic value of atrial pacing and thallium-201 scintigraphy in patients with stable chest pain
30. Predictive value of quantitative dipyridamole-thallium scintigraphy in assessing cardiovascular risk after vascular surgery in diabetes mellitus
31. Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease
32. Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease. Validation of models based on these tests
33. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease
34. Prognostic value of adenosine single-photon emission computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease
35. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain
36. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise
37. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months
38. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography
39. Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data
40. Independent and incremental prognostic value of exercise thallium single-photon emission computed tomographic imaging in women
41. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain
42. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification
43. Effective risk stratification using exercise myocardial perfusion SPECT in women: Gender-related differences in prognostic nuclear testing
44. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia
45. Prognostic characterization of patients with mild coronary artery disease with myocardial perfusion single photon emission computed tomography: Validation of an outcomes-based strategy
46. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction
47. Incremental prognostic value of rest-redistribution (201)Tl single-photon emission computed tomography
48. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography
49. Predictors of outcome of medically treated patients with left main/three-vessel coronary artery disease by coronary angiography
50. Independent and incremental prognostic value of (201)Tl lung uptake at rest in patients with severe postischemic left ventricular dysfunction
51. Enhanced prognostic stratification of patients with left ventricular hypertrophy with the use of single-photon emission computed tomography
52. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT
53. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
54. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: Executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina)
55. Prediction of cardiac events after uncomplicated myocardial infarction: A prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography
56. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction
57. Comparative value of maximal treadmill testing, exercise thallium myocardial perfusion scintigraphy and exercise radionuclide ventriculography for distinguishing high- and low-risk patients soon after acute myocardial infarction
58. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery
59. The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction: A prospective natural history study
60. Prediction of multivessel coronary artery disease and prognosis early after acute myocardial infarction by exercise electrocardiography and thallium-201 myocardial perfusion scanning
61. Noninvasive evaluation of cardiac risk before elective vascular surgery
62. Dipyridamole-thallium scanning in patients undergoing vascular surgery. Optimizing preoperative evaluation of cardiac risk
63. Acute myocardial infarction associated with single vessel coronary artery disease: An analysis of clinical outcome and the prognostic importance of vessel patency and residual ischemic myocardium
64. Dipyridamole-thallium 201 scintigraphy in the early post-infarction period. Safety and accuracy in predicting the extent of coronary disease and future recurrence of angina in patients suffering from their first myocardial infarction
65. Assessment by dipyridamole-thallium-201 myocardial scintigraphy of coronary risk before peripheral vascular surgery
66. Prognostic value of intravenous dipyridamole thallium scintigraphy after an acute myocardial ischemic event
67. Prognostic utility of predischarge dipyridamole-thallium imaging compared to predischarge submaximal exercise electrocardiography and maximal exercise thallium imaging after uncomplicated acute myocardial infarction
68. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery
69. Noninvasive cardiac risk stratification of diabetic and nondiabetic uremic renal allograft candidates using dipyridamole-thallium-201 imaging and radionuclide ventriculography
70. Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events
71. Perioperative and long-term prognostic value of intravenous dipyridamole thallium scintigraphy in patients with peripheral vascular disease
72. Postoperative myocardial infarction and cardiac death. Predictive value of dipyridamole-thallium imaging and five clinical scoring systems based on multifactorial analysis
73. Prognostic value of predischarge low-level exercise thallium testing after thrombolytic treatment of acute myocardial infarction
74. Prognosis following interventional therapy for acute myocardial infarction: Utility of dipyridamole thallium scintigraphy
75. Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction trials
76. Preoperative and long-term cardiac risk assessment. Predictive value of 23 clinical descriptors, 7 multivariate scoring systems, and quantitative dipyridamole imaging in 360 patients
77. Limited prognostic value of thallium-201 exercise treadmill testing early after myocardial infarction in patients treated with thrombolysis
78. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction
79. Early dipyridamole (99m)Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: Comparison with submaximal exercise imaging
80. Prediction of in-hospital cardiac events using dipyridamole-thallium scintigraphy performed very early after acute myocardial infarction
81. Prognostic significance of normal quantitative planar thallium-201 stress scintigraphy in patients with chest pain
82. Prognosis with chest pain and normal thallium-201 exercise scintigrams
83. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age
84. Prognostic implications of a negative dipyridamole-thallium scan: Results in 360 patients
85. Prognostic value of normal technetium-99m-sestamibi cardiac imaging
86. Extent of jeopardized viable myocardium determined by myocardial perfusion imaging best predicts perioperative cardiac events in patients undergoing noncardiac surgery
87. Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease
88. Prognostic implications of normal exercise tomographic thallium images in patients with angiographic evidence of significant coronary artery disease
89. Prognostic implications of normal exercise SPECT thallium images in patients with strongly positive exercise electrocardiograms
90. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging
91. Exercise treadmill score for predicting prognosis in coronary artery disease
92. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease
93. Transient left ventricular cavitary dilation during dipyridamole-thallium imaging as an indicator of severe coronary artery disease
94. Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease
95. A model to predict multivessel coronary artery disease from the exercise thallium-201 stress test
96. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables
97. Risk stratification and survival after myocardial infarction
98. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropylisonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction
99. Radionuclide assessment of ventricular function and risk stratification after myocardial infarction
100. Prognosis by measurements of left ventricular function during exercise
101. Prognostic value of 1-day stress/rest electrocardiogram-gated single-photon emission computed tomography using Tc-99m-labeled methoxy-isobutyl isonitrile
102. Prognostic value of simultaneous perfusion and function assessment using technetium-99m sestamibi
103. Identification of severe and extensive coronary artery disease by postexercise regional wall motion abnormalities in Tc-99m sestamibi gated single-photon emission computed tomography
104. Role of exercise thallium-201 myocardial perfusion scintigraphy in predicting prognosis in suspected coronary artery disease
105. Prognostic value of thallium-201 myocardial perfusion imaging in patients with unstable angina who respond to medical treatment
106. Hemodynamic determinants of thallium-201 lung uptake in patients during atrial pacing stress
107. Multivariate clinical models and quantitative dipyridamole-thallium imaging to predict cardiac morbidity and death after vascular reconstruction
108. Usefulness of dipyridamole-thallium scanning for preoperative evaluation of cardiac risk for nonvascular surgery
109. Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction
110. Myocardial perfusion scintigraphy: Effect on diagnostic and clinical management algorithms
111. Prognostic utility of myocardial viability assessment
112. Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy
113. The persistent defect on exercise thallium imaging and its fate after myocardial revascularization: Does it represent scar or ischemia?
114. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects
115. Sensitivity of myocardial fluorodeoxyglucose lumped constant to glucose and insulin
116. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose
117. Glucose for the heart
118. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake
119. Myocardial glucose uptake measured with fluorodeoxyglucose: A proposed method to account for variable lumped constants
120. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: Application of a new quantitative method using regional tracer kinetic information
121. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography
122. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans
123. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition
124. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography
125. "Functional" viability assessment by dual isotope F18-FDG and Tc99m-sestamibi in acute myocardial infarction
126. Identification of myocardial ischemia in areas of normal perfusion by rest-dual isotope SPECT with F18 deoxyglucose and Tc99m sestamibi in patients with unstable angina
127. Glucose uptake in the chronically dysfunctional but viable myocardium
128. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography
129. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography
130. Enhancement of myocardial [fluorine-18] fluorodeoxyglucose uptake by a nicotinic acid derivative
131. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo
132. The effect of insulin and FFA on myocardial glucose uptake
133. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging: A comparative study using different protocols
134. Hibernating myocardium
135. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans
136. Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting
137. Chronic myocardial hibernation in humans. From bedside to bench
138. Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction
139. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty
140. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
141. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization
142. Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function, and metabolism
143. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease
144. Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction
145. Identification and revascularization of hibernating myocardium in angina-free patients with left ventricular dysfunction
146. Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography
147. Only hibernating myocardium invariably shows early recovery after coronary revascularization
148. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease
149. PET scan predicts recovery of left ventricular function after coronary artery bypass operation
150. Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization
151. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure
152. Coronary revascularization for postischaemic heart failure: How myocardial viability affects survival
153. Correlation of preoperative myocardial function, perfusion, and metabolism with postoperative function at rest and stress after bypass surgery in severe left ventricular dysfunction
154. Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria
155. Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability
156. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism
157. Utility of positron emission tomography in predicting improved left ventricular ejection fraction after coronary artery bypass grafting among patients with ischemic cardiomyopathy
158. Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: Correlation with positron emission tomographic findings
159. Hibernating myocardium in post-ischaemic heart failure: Pathophysiology, identification and revascularisation
160. Prediction of functional recovery after revascularization in coronary artery disease using (18)F-FDG and (123)I-BMIPP SPECT
161. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography
162. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: Evidence for persistence of viable tissue in some infarct regions by positron emission tomography
163. Non-Q wave versus Q wave myocardial infarction: Regional myocardial metabolism and blood flow assessed by positron emission tomography
164. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET
165. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose
166. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
167. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dysynergic myocardium
168. [18F]fluorodeoxyglucose single photon emission computed tomography: Can it replace PET and thallium SPECT for the assessment of myocardial viability?
169. Thallium scintigraphy compared with 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction
170. Dobutamine-stress electrocardiographically gated positron emission tomography for detection of viable but dysfunctional myocardium
171. Hibernating myocardium: Morphological correlates of inotropic stimulation and glucose uptake
172. Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability
173. Diagnosis of myocardial viability by dual-head coincidence gamma camera fluorine-18 fluorodeoxyglucose positron emission tomography with and without non-uniform attenuation correction
174. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography
175. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography
176. Relation between myocardial uptake of thallium-201 chloride and fluorine-18 fluorodeoxyglucose imaged with single-photon emission tomography in normal individuals
177. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography
178. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography
179. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction
180. Comparative performance of gated perfusion SPECT wall thickening, delayed thallium uptake, and F-18 fluorodeoxyglucose SPECT in detecting myocardial viability
181. Agreement and disagreement between "metabolic viability" and "contractile reserve" in akinetic myocardium
182. Feasibility of planar fluorine-18-FDG imaging after recent myocardial infarction to assess myocardial viability
183. Myocardial F-18 fluorodeoxyglucose imaging by SPECT
184. F-18 fluorodeoxyglucose SPECT for assessment of myocardial viability
185. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera
186. FDG-SPECT: Correlation with FDG-PET
187. 180° versus 360° myocardial 511 keV single photon emission computed tomography (SPECT)
188. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability
189. Myocardial viability studies using fluorine-18-FDG SPECT: A comparison with fluorine-18-FDG PET
190. Fluorine 18-labeled fluorodeoxyglucose myocardial single-photon emission computed tomography: An alternative for determining myocardial viability
191. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: Comparison with stress thallium imaging
192. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease